Zhejiang Hisun Pharmaceutical Co., Ltd. Class ASSE: 600267

Announcement on Obtaining "Notice of Approval for Marketing Application of Chemical APIs" for Bedaquiline Fumarate API

· Issued by Zhejiang Hisun Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining "Notice of Approval for Marketing Application of Chemical APIs" for Bedaquiline Fumarate API

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis